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NIELS HJORTH, M.D.
Several hundreds of cases of untoward re-
actions from thiamine have been reported. They
have been described as including asthma,
urticaria, shock and even sudden death (1).
Apparently, they only occur after injections,
often late in a series of treatment with high doses.
Most of the reactions can hardly be considered
as allergic in nature, but are rather due to intol-
erance to the pharmacological action of thiamine
upon the autonomic nervous system (2).
Normally thiamine accentuates the various
effects of acetyicholine. As an expression of this
property many normal persons show an im-
mediate papular response to an intradermal in-
jection of thiamine (2, 3, 4). Because of this
phenomenon many of the reported reactions
have erroneously been interpreted as allergic (2).
Only in rare instances has it been possible to
verify the hypersensitivity by a positive Praus-
nitz-KUstner's test (3).
Allergic eczematous hypersensitivity to the
thiamine has only rarely been reported. Dalton
and Pierce (5) found positive patch tests to thia-
mine in 10 workers employed by a pharmaceutical
factory in handling this material. It is
not apparent from the report, whether the
thiamine was the actual cause of eczema. In a
similar firm, Rajka and Vincze (6) found that the
major cause of eczemas occurring among workers
employed in the synthesis of aneurin was one of
the intermediate compounds in the synthesis of
thiamine (viz. ethoxymalodinitril). Only one of
their cases showed at the same time a hyper-
sensitivity to pure thiamine. Another of the thia-
mine precursors, chlorpyrimidine, was the cause
of a Danish case of occupational dermatitis (7),
with positive patch tests to crude thiamine, but
negative reactions to purified thiamine from the
same factory.
Sensitization from contact solely with pure
thiamine has only been reported once (8). The
patients were two women, who were employed
in filling vials with thiamine solution and during
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this work had developed a nummular eczema of
both hands. Patch tests to pure aneurin were
positive, and the etiology was further confirmed
by the observation that relapse occurred after
the work was resumed.
These two cases are similar to the one reported
below. The investigation in the present case, how-
ever, has supplied details which supplement the
scanty knowledge of this peculiar hypersensi-
tivity.
THIAMINE
As shown in table 1 the molecule comprises a
thiazole and a pyrimidine component. The
hydrochloride forms a stable solution of pH 3.
When the pH is increased above 5 the thiamine
may be split by heating or ultraviolet radiation
into the thiazole and the pyrimidine components
(9).
After intestinal resorption the thiamine is
esterified with pyro-phosphoric acid and thus
changed to co-carboxylase, which is a co-enzyme
in the cellular metabolism. Part of the ingested
thiamine is eliminated in the urine as a pyrimi-
dine derivative (9). In sweat, even after excessive
doses, only minimal amounts are excreted (10).
The daily optimal intake is stated to be 1—3 mg
per day. In Denmark this is effected by thiamine
fortification of flour. The average intake from
this source averages 1—2 mg. per day.
CASE HISTORY
F. m. L. 303819. A 17 years old factory girl, who
had suffered from eczema in infancy, but had
otherwise been healthy.
In May 1955 she was employed at a pharmaceu-
tical firm, where she filled vials with different
vitamin preparations. After 4 months work an
eczema appeared on the fingers, the dorsum of
the hands, and the wrists. Later she developed a
perioral eczema. During a short absence from the
work the eczema disappeared, only to recur when
she resumed. By the end of October she was
referred for dermatological treatment.
Routine patch tests showed a hypersensitivity
to bichromate, but no chromate contact could be
ascertained. Several laboratory chemicals, in-
cluding phenol and benzyl alcohol gave negative
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TABLE 1
Patch Tests
Results of patch tests with components and derivatives of thiamine. Water was used diluent. Patch
tests were left for 48 hours and read after 48 and 72 hours. 1+ erythema, 3+ erythema, infiltration,
vesicles.
Substance Date Conc. Reaction
2-methyl-6-amino-5-amino-niethyl-pyrimidine
N=C—N112
C113.G C—CH2N112
I! II
N—CH
Sulfathiazol-cream
Sulfapyrimidine (Sulfadiazine)
Pure
10%
10%
1%
Hoffmann-la Roche Ltd.
reactions. Further patch tests with occupational
contactants led to the demonstration of posi-
tive reactions to thiamine, even in a 0.1% dilu-
tion. The patient had sometimes been employed
filling vials with thiamine and had noticed irri-
tation of the skin during this work. She further
supplied the information that she daily took a
tablet of vitamin B. This was found to contain 1
mg. of thiamine.
Under conservative treatment the eczema dis-
appeared after a few months. Afterwards the pa-
tient changed her occupation and from January
Pure
10%
1%
0.1%
0.01%
0.1%
10%
1%
0.1%
Pure
10%
Thiamine
Gil3
N=C—N112 C===C. 02H40H
II /
CH3C CCil2—Nliii
N—CH Cl Gil—S
Co-Carboxylase
Gil3
NC—NH2 C==Gil C2H4.P205(Oil)3/
C113•C C•C115—NIII
N—Gil Cl Gil—S
4-methyl-5- (oxyethyl) -thiazole
C CH='C C2il4 OR/N
CII S
N=G—Nil2
Cil3 G G—GH2Br
ii II
N—Gil
+
+
+
+++
+++
11/4/55
11/7/55
11/17/55
2/11/56
2/13/56
2/13/56
2/11/56
2/13/56
2/11/56
11/17/55
2/13/56
Pure
10%
5%
Pure
* A primary irritant.
The substances employed for patch testing were kindly supplied by
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1, 1956 she worked as a domestic servant employed
in dishwashing and cleaning without experiencing
any further irritation of the skin. She had no
contact with thiamine and took no vitamin B
tablets. After 6 weeks she returned for a follow
up examination, which disclosed only residual
traces of lichenification of the former patches
of eczema.
Experimental provocation: In the period of
treatment during which the patient continued her
work, a sudden flare-up of the eczema was ob-
served twice. On the first occasion it was revealed
that the patient, on her own initiative, had re-
sumed work filling thiamine vials.
The second time, the eczema flared up as a
result of experimental provocation. In order to
examine the effect of ingested thiamine two
coated tablets of 100 mg. thiamine each were
administered on the 6th of December 1955. Next
day the almost healed patches of eczema were
red and itching. An additional 100 mg. of thia-
mine was administered in a coated tablet. The
same day she had an acute relapse to the state
prior to treatment, but after a week the eruption
faded.
A similar relapse occurred 2 months after the
eczema had disappeared. At the control examina-
tion on the 11th February 1956 supplementary
patch tests, scratch- and intracutaneous tests
were performed (cf. table 1). Patch tests with
thiamine were positive as previously, and a cross-
reaction to co-carboxylase was demonstrated. In-
tracutaneous tests with 0.1 ml. of 0.1% solutions
of thiamine and co-carboxylase were negative.
4 days later similar intracutaneous tests with 0.1
ml. of 1% solutions and half an hour later with
10% solutions of the same substances were per-
formed (total dose of thiamine co-carboxylase 22
mg.). The four injections all provoked immedi-
ate papular response, as is the case in many nor-
mal persons.
Between 6 and 10 hours after the injections a
pruritic area of erythema appeared around the
mouth. Shortly after both hands and wrists were
similarly involved. Next day the pruritus had
subsided, but an intensely red, vesicular der-
matitis was found in all the formerly affected areas.
The 5 day old patch tests showed no focal re-
actions, but late papular reactions of 20 by 20
mm., without vesicles, had appeared at the sites
of the intracutaneous injections with thiamine
1% and 10%, while the co-carboxylase had given
a doubtful reaction.
Tinder treatment with zinc oxide lotion the
TABLE 2
Reactions to thiamine solutions of different
pH. Intradermal tests with 0.05 ml. in 20 patients.
pH
Wi
Average
eal. mm
Range
9.5—13.5Thiamine HCI, 4% 3 11.25
Thiamine, 4% 5.6 10.25 7—13.5
dermatitis disappeared with scaling within ten
days.
CONTROLS
Consecutive dermatological patients served as
controls.
Patch tests with thiamine 50% in water and
with co-carboxylase 1 % in water were negative
in 100 patients. Patch tests with pure methyl-
amino-bromomethyl-pyrimidin (cf. table 1) were
done on 34 patients of which 6 showed positive
reactions clinically of the primary irritancy type.
All had negative reactions to a 10% solution (and
to thiamine). Later 122 patients were tested with
a 10% solution of the same pyrimidine deriva-
tive. One patient showed a positive eczematous
reaction to a 10% and a 5% solution, but nega-
tive reaction to thiamine. The cause of the posi-
tive reaction could not be ascertained.
Intracutaneous tests with thiamine confirmed
that this substance normally produces a wheal
and a flare. If 5% and 10% solutions are em-
ployed such reactions are often accompanied by
pseudopods.
Similar reactions may, however, be provoked
in many normal persons by intracutaneous tests
with 1% acetic acid which has about the same
pH as a thiamine solution.
In order to determine whether the whealing
effect of thiamine might be due to the low pH of
the solutions, the reactions to a 4% solution of
thiamine were compared to those of a thiamine
solution of pH 5.6. The latter solution was pre-
pared by mixing equal parts of a 2 normal NaOH
with an 8% solution of thiamine, Owing to the
instability of thiamine at the resulting pH of
5.6 the solution was prepared immediately before
use and discarded after 60 minutes. The results
(of. table 2) confirmed that the reactions are due
to some specific action of thiamine.
The whealing after intracutaneous injections
of thiamine is generally attributed to an
enhancing effect upon the cholinergic nervous
system (2,4). In two patients, however, with cho-
264 TIlE JOURNAL OF INVESTIGATIVE DERMATOLOGY
linergic urticaria and a verified high sensitivity
to cholinergic substances, intracutaneous re-
actions to thiamine did not show any peculiari-
ties.
Intracutaneous tests with co-carboxylase 1 %
0.05 ml. were performed in 30 patients and
showed in 25 cases a wheal ranging from 5 to 14
mm. accompanied by a flare up to 40 mm. The
flare remained for more than 20 minutes. 5% and
10% solutions provoked similar reactions but
left a central necrosis, probably owing to the
strongly acid reaction (pH 1.5—1.8).
DISCUSSION
Of special interest in the present case is the
relapse of eczema provoked by the ingestion of
thiamine. Dalton and Pierce (5) administered
thiamine by mouth, in unstated dosage, to ten
patients with positive patch tests to aneurin. No
"untoward signs or symptoms resulted." In the
present case the eczema relapsed after ingestion
of a dose of thiamine far above the physiological
requirements, but of a size used therapeutically.
However, the dose of tolerance could not be de-
termined owing to the reluctance of the patient
to permit further tests.
It is particularly striking that a vitamin which
normally plays an essential part in cellular me-
tabolism should have antigenic properties. So
it might be presumed that the primary allergen
is an impurity, possibly a decomposition product,
which under occupational conditions of exposure,
might occur in sufficient concentration for sensi-
tizing.
Impurities, however, could not explain the
hypersensitivity in the present case, where patch
tests with pure crystalline preparations from
different sources (Merck; la Roche) were all posi-
tive.
The decomposition products have not been
tested in any of the previously reported cases
of hypersensitivity to thiamine. Sensitization to
these products might occur since thiamine is
unstable at the prevailing pH of the skin surface.
Patch tests with the pyrimidine-component
of thiamine pure and in 10% solutions were posi-
tive, but repeated tests with 10% and 1% solu-
tions were negative (cf. table 1). As thiamine
elicited positive reactions even in 0.1% solutions,
it is unlikely that the decomposition products
Could be the primary allergen.
Although the pyrimidine derivative employed
for the tests is a primary irritant, the reactions
provoked by it might be an expression of a cross-
sensitization or secondary allergy, provided the
pyrimidine part was the antigenic determinant
group of the thiamine molecule. This cross-sensi-
tization should, however, have included the
amino-methyl-pyrimidirie, which was tested but
with a negative result. Thus the observed reac-
tions from the bromo-methyl-pyrimidine must
have been due to the primary irritant properties
of the substance, and it may be concluded that
the primary allergen in this case was the whole
thiamine molecule.
Considering the chemical structures it is un-
derstandable that a cross-reaction to co-car-
boxylase could be demonstrated. This is, how-
ever, of some theoretical interest, as it seems to
be the first demonstration of a hypersentitivity to
a pure co-enzyme.
SUMMARY
1. A case of occupational dermatitis from thia-
mine is reported. Relapses of the eczema occurred
after ingestion of thiamine (200 mg.) and later
after intracutaneous injection of 10 mg thiamine.
2. Patch tests with the components indicated
that the antigenic determinant was the whole
molecule.
3. A secondary allergy to co-carboxylase was
demonstrated.
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